However, since only some of the studied animal models with elevated FGF23 develop kidney injury or hyperphosphatemia, while all of them show increases in serum concentrations of inflammatory cytokines (163), it is possible that FGF23 acts as a major driver of inflammation in CKD. This evidence concerns the gene FGF23 and chronic kidney disease.